Sponsor:
Indiana University
Code:
NCT04250259
Conditions
Alcoholic Cirrhosis
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Accepted
Interventions
Placebo
SAMe 400 mg tablet
Brief summary:
Conditions
Alcoholic Cirrhosis
Study ID
NCT04250259
Start date
Oct 22, 2020
Status verified date
Mar, 2026
Completion date
Mar 1, 2027
Anticipated
Primary completion date
Mar 1, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70
Healthy Volunteers: Accepted
Enrollment
196 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
placebo comparator: Placebo
experimental: 1,200 mg SAMe
no intervention: Non-drinking Controls
Interventions
Placebo
SAMe 400 mg tablet
Primary outcome measure
Central contacts
Locations
Cedars-Sinai Medical Center
Recruiting
Los Angeles, California, United States, 90048
Contacts
Indiana University Hospital
Recruiting
Indianapolis, Indiana, United States, 46202
Contacts
Principal Investigator:
Suthat Liangpunsakul, MD
Sponsor
Indiana University
Last update posted
Mar 31, 2026
Last verified
Mar, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-10-02. This information was provided to ClinicalTrials.gov by Indiana University on 2026-03-31. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.